GlassScriptPhysician profile
Monquen Huang
NPI 1477782035
$9,697.46
in general payments reported to CMS, 2019-2025
54 companies · $834 in 2025
The $834 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,159 · 2020: $1,010 · 2021: $1,280 · 2022: $1,464 · 2023: $1,641 · 2024: $1,310 · 2025: $834.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,713 · Education: $71.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,712.99 |
| Education | $71.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,889.38 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $715.30 | 2019-2023 | |
| Lilly USA, LLC | $575.16 | 2019-2025 | Amyvid, Kisunla, Emgality |
| Csl Behring | $538.23 | 2019-2025 | Hizentra |
| Biogen, INC. | $530.28 | 2019-2025 | Vumerity, Leqembi, Tysabri |
| Amgen INC. | $475.18 | 2019-2025 | Uplizna, Aimovig |
| Ucb, INC. | $420.91 | 2019-2025 | Briviact, Rystiggo |
| Mdd US Operations, LLC | $340.03 | 2019-2025 | Gocovri, Gocovri, Apokyn |
| Allergan, INC. | $331.52 | 2019-2022 | |
| Alexion Pharmaceuticals, INC. | $311.80 | 2019-2024 | Soliris, Ultomiris |
| Emd Serono, INC. | $287.15 | 2019-2024 | Mavenclad |
| Acadia Pharmaceuticals INC | $277.92 | 2019-2025 | Nuplazid |
| Amneal Pharmaceuticals LLC | $260.49 | 2019-2025 | Rytary, Crexont |
| Genzyme Corporation | $202.23 | 2019-2021 | |
| Lundbeck LLC | $195.59 | 2020-2025 | Vyepti, Rexulti |
Show all 54 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Monquen Huang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.